FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Mayne Pharma Lexette Recall

Lexette (halobetasol propionate) Topical Foam, 0

Mayne Pharma Inc · Greenville, NC

Risk level
Class II
Reported by FDA
Jan 26, 2022
Recall ID
D-0387-2022
Check your lot numberHow we source this data

Summary

Mayne Pharma recalled Lexette starting Jan 14, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0387-2022 on Jan 26, 2022. Reason: CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam. Status: Ongoing.

Why it was recalled

CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.

Product description

Lexette (halobetasol propionate) Topical Foam, 0.05% 50 g canisters, Rx ONLY, Distributed by: Mayne Pharma Greenville, NC 27834, NDC 51862-604-50

Lot numbers, UPCs & expiration codes

Lot #: 32451 Exp. 03/2022; 32532 Exp. 04/2022; 32552 Exp. 05/2022; 32701 32733 Exp. 10/2022; 32855 Exp. 02/2023; 32872 Exp. 03/2023.

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0387-2022
Classification
Class II
Status
Ongoing
Recall initiated
Jan 14, 2022
FDA report date
Jan 26, 2022
Quantity
17,113 canisters
Recall type
Voluntary: Firm initiated
Recalling firm
Mayne Pharma Inc

Original FDA data

Every field from FDA enforcement report D-0387-2022, exactly as published.

Show all FDA fields
City
Greenville
State
NC
Status
Ongoing
Country
United States
Event ID
89397
Address
1240 Sugg Pkwy
Code information
Lot #: 32451 Exp. 03/2022; 32532 Exp. 04/2022; 32552 Exp. 05/2022; 32701 32733 Exp. 10/2022; 32855 Exp. 02/2023; 32872 Exp. 03/2023.
Postal code
27834-9006
Report date
Jan 26, 2022
Product type
Drugs
Recall number
D-0387-2022
Classification
Class II
Recalling firm
Mayne Pharma Inc
Product quantity
17,113 canisters
Reason for recall
CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lexette (halobetasol propionate) Topical Foam, 0.05% 50 g canisters, Rx ONLY, Distributed by: Mayne Pharma Greenville, NC 27834, NDC 51862-604-50
Distribution pattern
Nationwide within the United States
Recall initiation date
Jan 14, 2022
Initial firm notification
Letter
Center classification date
Jan 19, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0387-2022, published Jan 26, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls